NCT02689726
Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
Phase: Phase 1
Role: Collaborator
Start: Aug 31, 2015
Completion: Aug 31, 2016